ADMA Biologics, Inc. (ADMA) Balance Sheet
As of 2026-06-30 (10-Q), ADMA Biologics, Inc. (ADMA) reported total assets of $684.2M, total liabilities of $276.0M and shareholders' equity of $408.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $136.0M. Long-term debt: $192.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADMAADMA Biologics, Inc.Follow ADMA — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- 15.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 12.5 | 26.1 | 17.2 | 10.4 | 9.9 | 43.1 | 26.8 | 26.8 | 55.9 | 51.1 | 86.5 | 51.4 | 103.1 | 87.6 | 136.0 | |
| Short-term investments | 0.0 | 2.9 | 4.7 | 6.4 | 5.4 | 0.0 | — | — | — | — | — | — | — | — | — | |
| Receivables | 0.0 | 0.0 | 0.4 | 0.9 | 1.0 | 3.9 | 1.4 | 3.5 | 13.2 | 28.6 | 15.5 | 27.4 | 50.0 | 158.4 | 138.2 | |
| Inventory | 1.3 | 1.7 | 1.7 | 3.4 | 5.0 | 12.6 | 18.6 | 53.1 | 81.5 | 124.7 | 163.3 | 172.9 | 170.2 | 206.5 | 239.3 | |
| Current assets | 13.9 | 31.1 | 24.1 | 21.3 | 21.7 | 62.3 | 44.5 | 85.8 | 153.7 | 208.7 | 270.4 | 257.0 | 331.4 | 466.5 | 528.2 | |
| Total assets | 15.6 | 32.0 | 27.0 | 23.7 | 23.7 | 108.0 | 88.9 | 127.1 | 207.7 | 276.3 | 348.5 | 329.2 | 488.7 | 624.2 | 684.2 | |
| Current liabilities | 1.8 | 3.7 | 4.2 | 4.2 | 11.2 | 9.4 | 9.6 | 14.0 | 19.9 | 30.4 | 39.3 | 49.8 | 55.5 | 69.5 | 75.8 | |
| Long-term debt | 3.8 | 4.9 | 14.6 | 14.2 | 12.3 | 25.4 | 26.4 | 68.3 | 93.0 | — | — | — | 72.3 | 69.3 | 192.8 | |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 2.8 | 3.8 | |
| Total liabilities | 6.1 | 10.4 | 21.0 | 22.9 | 28.1 | 67.7 | 69.1 | 100.9 | 119.4 | 135.1 | 196.5 | 194.0 | 139.7 | 146.9 | 276.0 | |
| Shareholders' equity | 9.4 | 21.6 | 6.0 | 0.8 | -4.5 | 40.3 | 19.8 | 26.2 | 88.2 | 141.2 | 152.0 | 135.2 | 349.0 | 477.3 | 408.2 |
USD millions · SEC XBRL
ADMA Biologics, Inc. — questions
- How much cash does ADMA Biologics, Inc. have?
- $136.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does ADMA Biologics, Inc. have?
- $192.8M of long-term debt and $3.8M due within a year as of 2026-06-30.
- What are ADMA Biologics, Inc.'s total assets?
- $684.2M as of 2026-06-30.
- What is ADMA Biologics, Inc.'s shareholders' equity?
- $408.2M as of 2026-06-30.
Every figure on this page comes from ADMA Biologics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.